Final hours! Save up to 55% OFF InvestingProCLAIM SALE

Saakshi Medtech and Panels makes strong debut on NSE SME platform

EditorMalvika Gurung
Published 10/03/2023, 03:07 AM
© Reuters.

Saakshi Medtech and Panels, led by Aniket Vijay Latkar and Chitra Vijay Latkar, made a robust entry into the NSE SME platform on Tuesday. The company's shares registered a substantial premium of 50.5%, indicating a positive response from investors.

The company managed to raise Rs 45.16 crore ($6.08 million) through an initial public offering (IPO) that was oversubscribed 91.65 times. This successful IPO allowed Saakshi Medtech and Panels to issue a fresh batch of 46.56 lakh shares, further expanding its market presence.

The capital raised from the IPO will be employed for several purposes. A significant portion is earmarked for debt clearance, which will strengthen the company's financial standing. Additionally, funds will be allocated to maintain operational fluidity, ensuring the smooth functioning of the business.

The remainder of the capital will be directed towards other corporate agendas. While the specifics of these agendas were not disclosed, it is expected that they will involve strategic moves to enhance the company's market position and growth prospects.

This recent development underscores the potential of the NSE SME platform as a viable avenue for smaller companies to raise capital and grow their businesses. It also reflects investor confidence in Saakshi Medtech and Panels' business model and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.